Article AbstractLetter to the Editor Sir: Recent reports describe treatment of patients with refractory major depression using augmentation with the µ-opiate agonists oxycodone and oxymorphone and the partial agonist buprenorphine. We report a patient with refractory major depression who responded to tramadol hydrochloride monotherapy.
No takes yet. Share an insight, caveat, or question.
Shapira et al. (2001) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: